Protalix BioTherapeutics
PLX
#8687
Rank
โ‚น16.33 B
Marketcap
โ‚น202.78
Share price
1.42%
Change (1 day)
-8.12%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.90. In 2024 the company made an earnings per share (EPS) of โ‚น3.79 a decrease over its 2023 EPS that were of โ‚น11.37.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-53.96%
2024โ‚น3.79-66.67%
2023โ‚น11.37-138.71%
2022-โ‚น29.37-50%
2021-โ‚น58.75181.82%
2020-โ‚น20.85-82.11%
2019-โ‚น116.55-31.67%
2018-โ‚น170.56-72.31%
2017-โ‚น615.92124.14%
2016-โ‚น274.80-147.54%
2015โ‚น578.02-290.63%
2014-โ‚น303.226.67%
2013-โ‚น284.27130.77%
2012-โ‚น123.18-69.77%
2011-โ‚น407.4619.44%
2010-โ‚น341.13-12.2%
2009-โ‚น388.5036.67%
2008-โ‚น284.27-37.5%
2007-โ‚น454.8350%
2006-โ‚น303.223.23%
2005-โ‚น293.75138.46%
2004-โ‚น123.18-74%
2003-โ‚น473.79-0%
2002-โ‚น473.79-50%
2001-โ‚น947.57233.33%
2000-โ‚น284.27-84.21%
1999-โ‚น1,800-24%
1998-โ‚น2,369-600%
1997โ‚น473.79-16.67%
1996โ‚น568.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น128.87 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น456.73 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.42-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น117.50 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel